News, Money and Drugs for Friday, May 8, 2009
May 8, 2009 at 10:02 pm EST | Tags: News
Obama says he wants to add $300M to FDA, focus on food and drug safety issues [WSJ]
Oh no!! Pfizer, Auxilium Peyronie’s drug, Xiaflex (collagenase), causes “swelling, redness and bruising.” Ouch!!! [BNET Pharma]
Cell Therapeutics only has cash to last to August, Pixantrone cardiac issues still a concern. [Xconomy]
Targeted Genetics running out of options, might close up shop despite die-hards going to bat on our comments section right here. [Xconomy]
Pfizer said its committing $100M into its international stem cell development program; Cambridge, UK to be hub. [FierceBiotech]
Archimedes Pharma says its intranasal fentanyl, NasalFent, is superior to immediate-release morphine in relieving cancer pain. [ITnews]
Finally, the WSJ Health Blog takes a look at HCG and Manny Ramirz, yeah, that dude from the Los Angeles Dodgers that got suspended for 50 games. [WSJ Health Blog]
Image from fda
![[Loading...]](http://www.iguanabio.com/wp-content/themes/IguanaBio/images/ajax-loader.gif){kind=small}
Xconomy has their numbers wrong, total proceeds from the single investor was $23.8 million, not $15million, and what’s to prevent CTI from raising more money? CTI stock has risen 2,000 % since March 2, something Xconomy doesn’t mention,—how come?